Cardinal Health, Inc (NYSE: CAH)’s stock price has dropped by -3.64 in relation to previous closing price of 116.13. Nevertheless, the company has seen a gain of 0.93% in its stock price over the last five trading days. seekingalpha.com reported 2024-11-04 that Cardinal Health’s Q1 2025 earnings reaffirm my buy rating due to a strengthening pharmacy business and industry tailwinds. Despite initial market overreaction to 2025 guidance, Cardinal Health’s management is transparently mitigating risks. A DCF analysis suggests a price target of $128 for CAH stock, offering a 17% upside.
Is It Worth Investing in Cardinal Health, Inc (NYSE: CAH) Right Now?
Cardinal Health, Inc (NYSE: CAH) has a price-to-earnings ratio of 21.75x that is above its average ratio. Additionally, the 36-month beta value for CAH is 0.60. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 15 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CAH is 241.29M and currently, short sellers hold a 3.09% ratio of that float. The average trading volume of CAH on November 05, 2024 was 1.90M shares.
CAH’s Market Performance
CAH’s stock has seen a 0.93% increase for the week, with a -0.07% drop in the past month and a 12.44% gain in the past quarter. The volatility ratio for the week is 3.26%, and the volatility levels for the past 30 days are at 1.80% for Cardinal Health, Inc The simple moving average for the past 20 days is -0.05% for CAH’s stock, with a 5.97% simple moving average for the past 200 days.
Analysts’ Opinion of CAH
Many brokerage firms have already submitted their reports for CAH stocks, with Leerink Partners repeating the rating for CAH by listing it as a “Outperform.” The predicted price for CAH in the upcoming period, according to Leerink Partners is $125 based on the research report published on February 26, 2024 of the current year 2024.
Barclays gave a rating of “Overweight” to CAH, setting the target price at $117 in the report published on January 03rd of the current year.
CAH Trading at 0.15% from the 50-Day Moving Average
After a stumble in the market that brought CAH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -6.07% of loss for the given period.
Volatility was left at 1.80%, however, over the last 30 days, the volatility rate increased by 3.26%, as shares surge +0.13% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2.25% upper at present.
During the last 5 trading sessions, CAH rose by +0.93%, which changed the moving average for the period of 200-days by +6.09% in comparison to the 20-day moving average, which settled at $111.96. In addition, Cardinal Health, Inc saw 11.01% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CAH starting from Mayer Jessica L, who sale 16,573 shares at the price of $109.39 back on Aug 21 ’24. After this action, Mayer Jessica L now owns 75,971 shares of Cardinal Health, Inc, valued at $1,812,920 using the latest closing price.
Mayer Jessica L, the Officer of Cardinal Health, Inc, proposed sale 16,573 shares at $109.39 during a trade that took place back on Aug 21 ’24, which means that Mayer Jessica L is holding shares at $1,812,898 based on the most recent closing price.
Stock Fundamentals for CAH
Current profitability levels for the company are sitting at:
- 0.01 for the present operating margin
- 0.03 for the gross margin
The net margin for Cardinal Health, Inc stands at 0.01. The total capital return value is set at 0.26.
Based on Cardinal Health, Inc (CAH), the company’s capital structure generated 2.74 points at debt to capital in total, while cash flow to debt ratio is standing at 0.3. The debt to equity ratio resting at -1.58. The interest coverage ratio of the stock is 29.9.
Currently, EBITDA for the company is 2.86 billion with net debt to EBITDA at 0.83. When we switch over and look at the enterprise to sales, we see a ratio of 0.13. The receivables turnover for the company is 19.06for trailing twelve months and the total asset turnover is 5.21. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.95.
Conclusion
In conclusion, Cardinal Health, Inc (CAH) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
